TP53 and inflammatory myofibroblastic tumor: Abnormal p53 staining (null or strong/diffuse) has been observed in ULMS with 70% sensitivity and 100% specificity against inflammatory myofibroblastic tumors (IMTs) and is related to genomic alterations (29).